Segment Reporting (Tables)

12 Months Ended

Jun. 30, 2012

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The table below sets forth loss from continuing operations for the years ended June 30, 2012 and 2011.

	Segment Statements of Operations —Years ended June 30, (in thousands)
	Escalon Clinical Diagnostics						Sonomed Escalon					Corporate						Total
	2012			2011			2012		2011			2012			2011			2012			2011
Revenues, net:
Product revenue	$	12,985		$	13,709		$	11,462	$	11,867		$	—		$	—		$	24,447		$	25,575
Total revenue, net	12,985			13,709			11,462		11,867			—			—			24,447			25,575
Costs and expenses:
Cost of goods sold	9,416			10,775			5,760		6,475			—			—			15,176			17,250
Marketing, general & admin	5,297			6,124			4,226		3,702			501			853			10,024			10,679
Research & development	476			725			1,005		877			—			—			1,481			1,603
Goodwill impairment	—			—			—		906			—			—			—			906
Total costs and expenses	15,189			17,625			10,991		11,960			501			853			26,681			30,438
(Loss) income from operations	(2,204		)	(3,916		)	471		(93		)	(501		)	(853		)	(2,234		)	(4,863		)
Other (expense) and income:
Loss on disposal of assets	(87		)	—			—		—			—			—			(87		)	—
Equity in OTM	—			—			—		—			7			(70		)	7			(70		)
Interest income	—			—			—		—			—			—			—			—
Interest expense	(166		)	(324		)	—		—			(178		)	—			(344		)	(324		)
Total other (expense) and income	(253		)	(324		)	—		—			(171		)	(70		)	(424		)	(394		)
(Loss) and income before taxes	(2,457		)	(4,240		)	471		(93		)	(672		)	(923		)	(2,658		)	(5,256		)
Income taxes benefit from continuing operations	—			—			—		—			—			(240		)	—			(240		)
Net (loss) income from continuing operations	$	(2,457	)	$	(4,240	)	$	471	$	(93	)	$	(672	)	$	(683	)	$	(2,658	)	$	(5,016	)

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas

	2012			2011
ECD	$	211,234		$	84,056
Sonomed-Escalon	5,717,769			5,859,438
Total	$	5,929,003		$	5,943,494
Total Net Revenue	$	24,446,525		$	25,575,276
	24.3		%	23.2		%